Kern Capital
Overview
Kern Capital manages a diversified portfolio stretching from new ventures to established and profitable businesses across many industry sectors, but with a particular focus on the life sciences . The firm tends to make investments of $5 to $15 million in only a few companies each year and partners with outstanding management teams for the long term .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GPN Vaccines | Jun 2024 | Series B Extension | Co-investor |
| Latigo Biotherapeutics | Mar 2025 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kern Capital based?
Kern Capital is headquartered in Larkspur, California, United States.
When was Kern Capital founded?
Kern Capital was founded in 2007.
How many portfolio companies does Kern Capital have?
Kern Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Kern Capital's portfolio?
Portfolio companies visible on Caplight include GPN Vaccines, Latigo Biotherapeutics.
What was Kern Capital's most recent investment shown here?
Kern Capital's most recent investment in this portfolio sample was in Latigo Biotherapeutics in 2025.
What sectors does Kern Capital focus on?
Kern Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Kern Capital focus on?
Kern Capital typically invests at the Mid stage.
What is Kern Capital's AUM?
Kern Capital's assets under management are estimated between $50.0M and $100.0M.